Elevation of IL-6 and CRP are well-recognized features of cancer progression and considered predictors of poor prognosis and survival, and are found to be associated with chemotherapy resistance in breast [47], colorectal [48], lung [49], and gastrointestinal cancers [50,51]. Here, CRP is linked to cancer.